UPDATE: MLV Initiates Coverage On Tenax Therapeutics By: Benzinga via Benzinga December 16, 2014 at 14:13 PM EST Analysts at MLV & Co on Tuesday initiated coverage of Tenax Therapeutics Inc (NASDAQ: TENX) with a Buy rating and $7 price ... Read More >>